Assembly Biosciences ASMB Current ratio

Current ratio at other companies

Arrowhead ResearchARWR

6.2×+1.1×

ALN

Alnylam PharmaceuticalsALNY

3.1×+0.3×

Avalo TherapeuticsAVTX

19.3×+6.9×

Arbutus Biopharma CorporationABUS

54.3×+48.3×

Vir Biotechnology, Inc.VIR

6×-1.0×

Absci CorporationABSI

10.6×+6.2×

FAQ

What is Assembly Biosciences's current ratio?

Assembly Biosciences (ASMB) reported current ratio of 6.6× in Q1 2026.

How has Assembly Biosciences's current ratio changed year-over-year?

Assembly Biosciences's current ratio increased by 224.5% year-over-year, from 2× to 6.6×.

What is the long-term trend for Assembly Biosciences's current ratio?

Over 5 years (2020 to 2025), Assembly Biosciences's current ratio has grown at a -10.7% compound annual growth rate (CAGR), from 9.2× to 5.2×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.